Targeting a key gene before birth could someday help lead to a treatment for Down syndrome by reversing abnormal embryonic brain development and improving cognitive function after birth, according to a Rutgers-led study by researchers at Rutgers-New Brunswick and Rutgers Robert Wood Johnson Medical School.
Recent Posts
- Anonymous Distribution of Naloxone via Vending Machines Raises Uptake by Ex-Prisoners, Rutgers Researchers Find.
- New NJACTS Publication
- Rutgers Researchers Help Redefine Core Microbiome, Opening New Chapter in Precision Health.
- Interested in Accessing Clinical Data?
- Rutgers Health has big plans to spend $47.5M on new ideas at gleaming new Helix tower.
Categories
- Community (2,072)
- Covid (979)
- CTO Events (5)
- News (2,633)
- Pilots (20)